Sponsor Pipeline

Guliz Ozgun Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07338981 The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI)… Advanced Kidney Cancer Not Yet Recruiting
NCT07346053 The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults… Advanced Bladder Cancer Not Yet Recruiting
Disease Areas
Kidney Cancer (1) Bladder Cancer (1)
Get alerts when Guliz Ozgun's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free